Skip to main content
Professional Technical In the Industry Vocabulary Test

MSAFP

Also written as: MSAFP — maternal serum alpha-fetoprotein

Maternal serum alpha-fetoprotein test used to screen for neural tube defects and chromosomal abnormalities during pregnancy.

Full Definition

Maternal serum alpha-fetoprotein (MSAFP) is a blood test performed during the second trimester of pregnancy, typically between 15-20 weeks gestation, to screen for certain birth defects. Alpha-fetoprotein is a protein produced by the fetal liver, and abnormal levels in maternal blood can indicate various conditions. Elevated levels may suggest neural tube defects, abdominal wall defects, or multiple gestations, while decreased levels may indicate increased risk of chromosomal abnormalities such as Down syndrome. This test is often part of a broader screening panel including other serum markers.

Usage

Usage note: Always specify 'maternal serum' to distinguish from amniotic fluid AFP.

In Context

  • "MSAFP levels were reported as 2.5 multiples of the median, prompting referral for targeted ultrasound." — Laboratory screening report

Also known as

maternal serum alpha-fetoprotein

Don't confuse with

AFP amniotic fluid alpha-fetoprotein

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON